A notable advancement in diabetes management is emerging with the introduction of tirzepatide in a 45mg form. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and https://thefairlist.com/story11538377/significant-approach-tirzepatide-strength-for-diabetes-control